Revenue
265 thousand USD
2027 Q1 · USD
Exact inputs and evidence
- Revenue: 265000 USD Source
Annual consolidated revenue for 2025: about USD 1.271M, using the latest reported figures. The previous period, 2024, was about USD 1.345M.
265 thousand USD
2027 Q1 · USD
-1,050.57%
2027 Q1 · %
-1.35 million USD
2027 Q1 · USD
-1.36 million USD
2027 Q1 · USD
331000 USD
102417178 shares
21.72% · 18.3 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-14.
Financial data available through: 2025-03-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 1.35 million
–
Current period
USD 1.27 million
–
1271000 − 1345000 = -74000 USD
1345000 USD · 2023-04-01 – 2024-03-31
Inspect prior input Prior source1271000 USD · 2024-04-01 – 2025-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 13 million
–
Current period
−USD 7.1 million
–
-7100000 − -13000000 = 5900000 USD
-13000000 USD · 2023-04-01 – 2024-03-31
Inspect prior input Prior source-7100000 USD · 2024-04-01 – 2025-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 5.2 million
–
Current period
−USD 4.8 million
–
-4795000 − -5199000 = 404000 USD
-5199000 USD · 2023-04-01 – 2024-03-31
Inspect prior input Prior source-4795000 USD · 2024-04-01 – 2025-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 138,000
–
Current period
USD 112,000
–
112000 − 138000 = -26000 USD
138000 USD · 2023-04-01 – 2024-03-31
Inspect prior input Prior source112000 USD · 2024-04-01 – 2025-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2015-04-01 – 2016-03-31 | 6366550 | 9272260 Derived | -2905710 | -97466 Derived | -2808244 | -279887 Derived | Source
|
| 2017 2016-04-01 – 2017-03-31 | 580372 | 2634757 Derived | -2054385 | -187125 Derived | -1867260 | -1536754 Derived | Source
|
| 2018 2017-04-01 – 2018-03-31 | 2193000 | 3982000 Derived | -1789000 | -3000 Derived | -1786000 | -2067000 Derived | Source
|
| 2019 2018-04-01 – 2019-03-31 | 5116000 | 9759000 Derived | -4643000 | -546000 Derived | -4097000 | -3345000 Derived | Source
|
| 2020 2019-04-01 – 2020-03-31 | 4072000 | 10936000 Derived | -6864000 | 451000 Derived | -7315000 | -13066000 Derived | Source
|
| 2021 2020-04-01 – 2021-03-31 | 898000 | 9622000 Derived | -8724000 | 87000 Derived | -8811000 | -12270000 Derived | Source
|
| 2022 2021-04-01 – 2022-03-31 | 397000 | 15825000 Derived | -15428000 | -428000 Derived | -15000000 | -7698000 Derived | Source
|
| 2023 2022-04-01 – 2023-03-31 | 911000 | 12482000 Derived | -11571000 | -71000 Derived | -11500000 | -7357000 Derived | Source
|
| 2024 2023-04-01 – 2024-03-31 | 1345000 | 11143000 Derived | -9798000 | 3202000 Derived | -13000000 | -5337000 Derived | Source
|
| 2025 2024-04-01 – 2025-03-31 | 1271000 | 8717000 Derived | -7446000 | -346000 Derived | -7100000 | -4907000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 6366550 |
|
| 2017 | Revenue | 580372 |
|
| 2018 | Revenue | 2193000 |
|
| 2019 | Revenue | 5116000 |
|
| 2020 | Revenue | 4072000 |
|
| 2021 | Revenue | 898000 |
|
| 2022 | Revenue | 397000 |
|
| 2023 | Revenue | 911000 |
|
| 2024 | Revenue | 1345000 |
|
| 2025 | Revenue | 1271000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | -17.1% |
|
| 2017 | Year over year | -90.9% |
|
| 2018 | Year over year | 277.9% |
|
| 2019 | Year over year | 133.3% |
|
| 2020 | Year over year | -20.4% |
|
| 2021 | Year over year | -77.9% |
|
| 2022 | Year over year | -55.8% |
|
| 2023 | Year over year | 129.5% |
|
| 2024 | Year over year | 47.6% |
|
| 2025 | Year over year | -5.5% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | -45.6% |
|
| 2017 | Operating margin | -354% |
|
| 2018 | Operating margin | -81.6% |
|
| 2019 | Operating margin | -90.8% |
|
| 2020 | Operating margin | -168.6% |
|
| 2021 | Operating margin | -971.5% |
|
| 2022 | Operating margin | -3,886.1% |
|
| 2023 | Operating margin | -1,270.1% |
|
| 2024 | Operating margin | -728.5% |
|
| 2025 | Operating margin | -585.8% |
|
| 2016 | Net margin | -44.1% |
|
| 2017 | Net margin | -321.7% |
|
| 2018 | Net margin | -81.4% |
|
| 2019 | Net margin | -80.1% |
|
| 2020 | Net margin | -179.6% |
|
| 2021 | Net margin | -981.2% |
|
| 2022 | Net margin | -3,778.3% |
|
| 2023 | Net margin | -1,262.3% |
|
| 2024 | Net margin | -966.5% |
|
| 2025 | Net margin | -558.6% |
|
| 2016 | Free cash flow margin | -4.4% |
|
| 2017 | Free cash flow margin | -264.8% |
|
| 2018 | Free cash flow margin | -94.3% |
|
| 2019 | Free cash flow margin | -65.4% |
|
| 2020 | Free cash flow margin | -320.9% |
|
| 2021 | Free cash flow margin | -1,366.4% |
|
| 2022 | Free cash flow margin | -1,939% |
|
| 2023 | Free cash flow margin | -807.6% |
|
| 2024 | Free cash flow margin | -396.8% |
|
| 2025 | Free cash flow margin | -386.1% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | -157702 |
|
| 2017 | Operating cash flow | -1391077 |
|
| 2018 | Operating cash flow | -1931000 |
|
| 2019 | Operating cash flow | -3330000 |
|
| 2020 | Operating cash flow | -8677000 |
|
| 2021 | Operating cash flow | -10800000 |
|
| 2022 | Operating cash flow | -7462000 |
|
| 2023 | Operating cash flow | -7047000 |
|
| 2024 | Operating cash flow | -5199000 |
|
| 2025 | Operating cash flow | -4795000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | -279887 |
|
| 2017 | Free cash flow | -1536754 |
|
| 2018 | Free cash flow | -2067000 |
|
| 2019 | Free cash flow | -3345000 |
|
| 2020 | Free cash flow | -13066000 |
|
| 2021 | Free cash flow | -12270000 |
|
| 2022 | Free cash flow | -7698000 |
|
| 2023 | Free cash flow | -7357000 |
|
| 2024 | Free cash flow | -5337000 |
|
| 2025 | Free cash flow | -4907000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 26% |
|
| 2017 | Liabilities / assets | 34.9% |
|
| 2018 | Liabilities / assets | 25.7% |
|
| 2019 | Liabilities / assets | 2.6% |
|
| 2020 | Liabilities / assets | 8.4% |
|
| 2021 | Liabilities / assets | 8.5% |
|
| 2022 | Liabilities / assets | 11% |
|
| 2023 | Liabilities / assets | 13.2% |
|
| 2024 | Liabilities / assets | 26.1% |
|
| 2025 | Liabilities / assets | 27.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 1.2× |
|
| 2017 | Current assets / current liabilities | 2.78× |
|
| 2018 | Current assets / current liabilities | 1.37× |
|
| 2019 | Current assets / current liabilities | 30.44× |
|
| 2020 | Current assets / current liabilities | 9.12× |
|
| 2021 | Current assets / current liabilities | 9.93× |
|
| 2022 | Current assets / current liabilities | 6.19× |
|
| 2023 | Current assets / current liabilities | 3.41× |
|
| 2024 | Current assets / current liabilities | 1.58× |
|
| 2025 | Current assets / current liabilities | 1.28× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2015-04-01 – 2016-03-31 | −USD 2.81 million Exact valueExact value: -2808244 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 157,702 Exact valueExact value: -157702 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 122,185 Exact valueExact value: 122185 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 279,887 Calculation and evidence-157702 − 122185 USD Exact free cash flow: -279887 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2016-04-01 – 2017-03-31 | −USD 1.87 million Exact valueExact value: -1867260 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.39 million Exact valueExact value: -1391077 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 145,677 Exact valueExact value: 145677 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.54 million Calculation and evidence-1391077 − 145677 USD Exact free cash flow: -1536754 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2017-04-01 – 2018-03-31 | −USD 1.79 million Exact valueExact value: -1786000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.93 million Exact valueExact value: -1931000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 136,000 Exact valueExact value: 136000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.07 million Calculation and evidence-1931000 − 136000 USD Exact free cash flow: -2067000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2018-04-01 – 2019-03-31 | −USD 4.1 million Exact valueExact value: -4097000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.33 million Exact valueExact value: -3330000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 15,000 Exact valueExact value: 15000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.35 million Calculation and evidence-3330000 − 15000 USD Exact free cash flow: -3345000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2019-04-01 – 2020-03-31 | −USD 7.32 million Exact valueExact value: -7315000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.68 million Exact valueExact value: -8677000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4.39 million Exact valueExact value: 4389000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.07 million Calculation and evidence-8677000 − 4389000 USD Exact free cash flow: -13066000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2020-04-01 – 2021-03-31 | −USD 8.81 million Exact valueExact value: -8811000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10.8 million Exact valueExact value: -10800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.47 million Exact valueExact value: 1470000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.27 million Calculation and evidence-10800000 − 1470000 USD Exact free cash flow: -12270000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2021-04-01 – 2022-03-31 | −USD 15 million Exact valueExact value: -15000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.46 million Exact valueExact value: -7462000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 236,000 Exact valueExact value: 236000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.7 million Calculation and evidence-7462000 − 236000 USD Exact free cash flow: -7698000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-04-01 – 2023-03-31 | −USD 11.5 million Exact valueExact value: -11500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.05 million Exact valueExact value: -7047000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 310,000 Exact valueExact value: 310000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.36 million Calculation and evidence-7047000 − 310000 USD Exact free cash flow: -7357000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-04-01 – 2024-03-31 | −USD 13 million Exact valueExact value: -13000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.2 million Exact valueExact value: -5199000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 138,000 Exact valueExact value: 138000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.34 million Calculation and evidence-5199000 − 138000 USD Exact free cash flow: -5337000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2024-04-01 – 2025-03-31 | −USD 7.1 million Exact valueExact value: -7100000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.8 million Exact valueExact value: -4795000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 112,000 Exact valueExact value: 112000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.91 million Calculation and evidence-4795000 − 112000 USD Exact free cash flow: -4907000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
106 filings · 5,593 latest values · 5,593 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001326205, 1326205, IGC, edgar:1326205
Also known as IGC PHARMA, INC., IGC Pharma, Inc., INDIA GLOBALIZATION CAPITAL, INC., India Globalization Capital, Inc.